Jb Hi Fi Stock Quote JBH - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

66.60

Bid

73.43

Ask

63.13

Volume

0.00

0.00 Day's Range 0.00

43.40 52 Week Range 69.60

Market Cap

7.282B

Previous Close

66.60

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

350,317

Shares Outstanding

109,333,981

Dividend Yield

PE Ratio

13.88

Earnings Per Share (EPS)

4.8

Revenue

9.63B

Net Profit

524.6M

Sector

Radio,tv,cons Electr Stores

Industry

Radio,tv,cons Electr Stores

Website

www.jbhifi.com.au

Headquarters

Melbourne, Victoria, Aus

Founded

1970

Jb Hi Fi Limited is listed in the Radio,tv,cons Electr Stores sector of the Australian Stock Exchange with ticker JBH. The last closing price for Jb Hi Fi was AUD66.60. Over the last year, Jb Hi Fi shares have traded in a share price range of AUD 43.40 to AUD 69.60.

Jb Hi Fi currently has 109,333,981 shares outstanding. The market capitalization of Jb Hi Fi is AUD7.28 billion. Jb Hi Fi has a price to earnings ratio (PE ratio) of 13.88.

FeaturedELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES

Form 8-K - Current report

Alto Neuroscience Receives Funding Award from Wellcome Trust to Accelerate Development of ALTO-100 in Bipolar Depression Leveraging Precision Psychiatry Approach

– $11.7 million award will be used to advance ALTO-100, a first-in-class small molecule, in a 200-patient placebo-controlled, double-blind, randomized Phase 2b study in bipolar depression – –...

Alto Neuroscience Announces Enrollment Completion in Phase 2b Study of ALTO-100 in Major Depressive Disorder

– 300 patients enrolled in the study, including patients with and without the cognitive biomarker – – On track to report topline data in October 2024 – – Alto to host investor day focused on...

Form 4 - Statement of changes in beneficial ownership of securities

Alto Neuroscience Initiates Phase 2 Study of ALTO-101, a Novel PDE4 Inhibitor, in Cognitive Impairment Associated with Schizophrenia

– ALTO-101 has been shown to positively impact cognition and key cognition-related EEG markers in humans when delivered orally – – Novel transdermal formulation of ALTO-101 exhibited favorable...

Amit Etkin, M.D., Ph.D., Founder and CEO of Alto Neuroscience, Named an EY Entrepreneur Of The Year® 2024 Bay Area Award Winner

– Dr. Etkin recognized as a Bay Area winner out of 26 finalists by an independent panel of judges – – Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future across...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.33	0.497962879131	66.27	69.6	65.86	287730	67.25996224	DE
4	5.83	9.59354944874	60.77	69.6	53.01	310265	65.04686308	DE
12	6.45	10.72319202	60.15	69.6	47.51	350317	61.28523897	DE
26	8.55	14.7286821705	58.05	69.6	46.01	428311	61.11214612	DE
52	20.84	45.541958042	45.76	69.6	43.4	408795	55.05245081	DE
156	17.55	35.7798165138	49.05	69.6	36.69	489760	48.01869326	DE
260	36.41	120.602848625	30.19	69.6	20.79	551395	44.79601983	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
1ADAdAlta Limited	AUD 0.025 (0.00%)	0
14DO1414 Degrees Limited	AUD 0.008 (0.00%)	0
14DN1414 Degrees Limited	AUD 0.00 (0.00%)	0
14D1414 Degrees Limited	AUD 0.065 (0.00%)	0
13S13 Seeds Limited	0.00 (0.00%)	0
1ADAdAlta Limited	AUD 0.025 (0.00%)	0
14DO1414 Degrees Limited	AUD 0.008 (0.00%)	0
14DN1414 Degrees Limited	AUD 0.00 (0.00%)	0
14D1414 Degrees Limited	AUD 0.065 (0.00%)	0
13S13 Seeds Limited	0.00 (0.00%)	0
SQ2Block Inc	AUD 92.834 (0.00%)	292.91k
FMGFortescue Ltd	AUD 18.349 (0.00%)	201.47k
S32South32 Limited	AUD 3.053 (0.00%)	100k
RMDResmed Inc	AUD 31.869 (0.00%)	94.21k
PMTPatriot Battery Metals Inc	AUD 0.496 (0.00%)	77k